Assyro AI

Orange Book product · Brand (NDA)

SELENIOUS ACID

SELENIOUS ACID

Brand (NDA)NDA 209379TE APRX AM REGENT

At a glance

Aug 30, 2021

Approved

Brand (NDA)

Application

AP

TE code

2

Listed patents

Key dates

  1. Approval

    FDA approval date of this drug product.

    Aug 30, 2021

    4 yr 10 mo ago

  2. Today

  3. Patent 11998565 expires

    Listed drug product patent expiration.

    Jul 01, 2041

    in 15 yr 3 mo

  4. Patent 12150957 expires

    Listed method-of-use patent (U-4039) expiration.

    Jul 01, 2041

    in 15 yr 3 mo

Pharmaceutical detail

Active ingredient

SELENIOUS ACID

Strength

EQ 12MCG SELENIUM/2ML (EQ 6MCG SELENIUM/ML)

Dosage form

SOLUTION

Route

INTRAVENOUS

TE code

AP

Application

NDA 209379

Product number

003

Marketing status

RX

Reference listed drug (RLD)

Yes

Reference standard (RS)

Yes

Active-ingredient family

View full family

This is a reference-listed drug (RLD) — the basis for generic (ANDA) applications. Other products sharing this ingredient are listed below.

Listed patents (2)

Patents listed in the FDA Orange Book for this product, with expiration date and patent type.
PatentExpiresInType
11998565Jul 01, 2041in 15 yr 3 mo
Product
12150957Jul 01, 2041in 15 yr 3 mo
U-4039
Agent CTA Background

Your Next Submission Could Take 6+ Fewer Weeks and Cost $250K Less.